ATIM-14. ALLIANCE A071101: A PHASE II RANDOMIZED TRIAL COMPARING THE EFFICACY OF HEAT SHOCK PROTEIN PEPTIDE COMPLEX-96 (HSPPC-96) VACCINE GIVEN WITH BEVACIZUMAB VERSUS BEVACIZUMAB ALONE IN THE TREATMENT OF SURGICALLY RESECTABLE RECURRENT GLIOBLASTOMA
   QxMD         Google Scholar   
Citation:
Neuro-oncology vol 19 (Suppl 6) vi29
Meeting Instance:
SNO 2017
Year:
2017
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
4203  
Program:
OGC
Primary Committee:
Neuro-Onc
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180882, U10CA180821, U10CA180868, U24CA196171  
Corr. Author:
 
Authors:
                                 
Networks:
CA824, COLUMBIA, GA005, LAPS-IL036, LAPS-MN026, LAPS-OH007, LAPS-UT003, METROMIN, VA002   
Study
Alliance-A071101
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: